Medicare Benefits Schedule - Item 57410

Low-dose computed tomography (low-dose CT) scan of chest for the National Lung Cancer Screening Program, without intravenous contrast medium, where:

(a) the request states that the patient’s eligibility to participate in the National Lung Cancer Screening Program has been assessed and confirmed; and

(b) the service utilises the agreed nodule management protocol for standardised lung nodule identification, classification and reporting; and

(c) the service is bulk-billed

(R)

Bulk bill incentive

(Anaes.)

Fee: $338.75 Benefit: 75% = $254.10 85% = $287.95

(See para IN.0.19, IN.2.3 of explanatory notes to this Category)

• Previous - Item 57364
• Next - Item 57413

Out-of-hospital services attract higher benefits when they are bulk billed by the provider.

For all diagnostic imaging items (except those in Group 6 – Management of Bulk Billed Services and items 61369, 61466, 61485) benefits for bulk billed services are payable at 95% of the schedule fee for the item.

Related Items: 55028 55029 55030 55031 55032 55033 55036 55037 55038 55039 55048 55049 55054 55065 55066 55068 55070 55071 55073 55076 55079 55080 55084 55085 55118 55126 55127 55128 55129 55130 55132 55133 55134 55135 55137 55141 55143 55145 55146 55238 55244 55246 55248 55252 55274 55276 55278 55280 55282 55284 55292 55294 55296 55600 55603 55700 55703 55704 55705 55706 55707 55708 55709 55712 55715 55718 55721 55723 55725 55729 55736 55739 55740 55741 55742 55743 55757 55758 55759 55762 55764 55766 55768 55770 55772 55774 55812 55814 55844 55846 55848 55850 55852 55854 55856 55857 55858 55859 55860 55861 55862 55863 55864 55865 55866 55867 55868 55869 55870 55871 55872 55873 55874 55875 55876 55877 55878 55879 55880 55881 55882 55883 55884 55885 55886 55887 55888 55889 55890 55891 55892 55893 55894 55895 56001 56007 56010 56013 56016 56022 56028 56030 56036 56101 56107 56219 56220 56221 56223 56224 56225 56226 56233 56234 56237 56238 56301 56307 56401 56407 56409 56412 56501 56507 56553 56620 56622 56623 56626 56627 56628 56629 56630 56801 56807 57001 57007 57201 57341 57352 57353 57354 57357 57360 57362 57364 57410 57413 57506 57509 57512 57515 57518 57521 57522 57523 57524 57527 57541 57700 57703 57706 57709 57712 57715 57721 57901 57902 57905 57907 57915 57918 57921 57924 57927 57930 57933 57939 57942 57945 57960 57963 57966 57969 58100 58103 58106 58108 58109 58112 58115 58300 58306 58500 58503 58506 58509 58521 58524 58527 58700 58706 58715 58718 58721 58900 58903 58909 58912 58915 58916 58921 58927 58933 58936 58939 59103 59300 59302 59303 59305 59312 59314 59318 59700 59703 59712 59715 59718 59724 59733 59739 59751 59754 59763 59970 60000 60003 60006 60009 60012 60015 60018 60021 60024 60027 60030 60033 60036 60039 60042 60045 60048 60051 60054 60057 60060 60063 60066 60069 60072 60075 60078 60500 60503 60506 60509 60918 60927 61109 61310 61313 61314 61321 61324 61325 61328 61329 61340 61345 61348 61349 61353 61356 61357 61360 61361 61364 61368 61372 61373 61376 61381 61383 61384 61386 61387 61389 61390 61393 61394 61397 61398 61402 61406 61409 61410 61413 61414 61421 61425 61426 61429 61430 61433 61434 61438 61441 61442 61445 61446 61449 61450 61453 61454 61457 61461 61462 61469 61473 61480 61495 61499 61505 61523 61524 61525 61529 61541 61553 61559 61563 61564 61565 61612 61614 61620 61622 61628 61632 61647 61650 63001 63004 63007 63010 63040 63043 63046 63049 63052 63055 63058 63061 63064 63067 63070 63073 63101 63111 63114 63125 63128 63131 63151 63154 63161 63164 63167 63170 63173 63176 63179 63182 63185 63201 63204 63219 63222 63225 63228 63231 63234 63237 63240 63243 63271 63274 63277 63280 63301 63304 63307 63322 63325 63328 63331 63334 63337 63340 63361 63385 63388 63391 63395 63397 63401 63404 63416 63425 63428 63440 63443 63446 63454 63461 63464 63467 63470 63473 63482 63491 63494 63496 63497 63498 63499 63501 63502 63504 63505 63513 63531 63533 63541 63543 63545 63546 63547 63549 63560 63563 64990 64991

Patient eligibility for the National Lung Cancer Screening Program (NLCSP)

As per the Medical Services Advisory Committee’s (MSAC) recommendation, the patient:

• is aged 50 to 70 years and 364 days; and
• is asymptomatic (no signs or symptoms of lung cancer); and
• currently smoke or have quit smoking in the past 10 years; and
• have a history of cigarette tobacco smoking of at least 30 pack-years.

Patient eligibility is assessed and confirmed by the requesting healthcare provider in line with clinical judgement.

CT dose

Refer to current Royal Australian and New Zealand College of Radiologists (RANZCR) guidelines for appropriate low-dose CT dosage – www.ranzcr.com/college/document-library/nlcsp-low-dose-chest-ct-acquisition-guidelines.

Screening low-dose CT scan (MBS item 57410)

The Screening low-dose CT scan is the test individuals undertake approximately every 2 years when they participate in the NLCSP, i.e. it is the service performed at the beginning of a 2-yearly lung cancer screening round. Noting that not all screening rounds remain on a consistent 2-year cycle as this is dependent on findings and the nodule management protocol.

Screening low-dose CT scan is restricted to one scan within a 2-year screening round.

The National Cancer Screening Register will send screening reminders 3 months prior to the commencement of a new screening round. This is particularly relevant in rural and remote regions where access to GP services and radiology services might take longer. The individual may see a healthcare practitioner and present earlier following receipt of the screening reminder. This item may be claimed for services rendered within the 3-month period prior to commencement of the 2 year screening round. There is no time limit on when an individual can present for their Screening low-dose CT scan after 2 years, pending all other eligibility criteria is satisfied.

Interval low-dose CT scans (MBS item 57413)

This item allows for follow-up management of a patient who requires it following a Screening low-dose CT scan (item 57410).

Following the screening low-dose CT scan, some individuals will require clinical follow-up based on the nodule management guidelines. This item enables individuals to access subsequent low dose CT scans, noting there is no time restriction for when individuals must present for clinical follow-up within their screening round.

The Interval low-dose CT scan must either be linked to an initial Screening low-dose CT scan within the past two years OR linked to a previous Interval low-dose CT scan which occurred within the 2-year time period of a Screening low-dose CT scan.

Lung nodule identification, classification, and reporting system for low-dose CT scan

The lung nodule management protocols were developed based on the MSAC recommended nodule management guidelines, which are:

• PanCan for the first Screening low-dose CT scan
• LungRADS for subsequent Screening low-dose CT scans and Interval low-dose CT scans.

Reporting of low-dose CT scan results

Results of the Screening low-dose CT scan and Interval low-dose CT scans are required to be reported to the National Cancer Screening Register in line with the National Cancer Screening Register Rules 2017. The report on the service is submitted using a standardised reporting form and communicated back to the requesting healthcare provider per usual practice.

Exemption to supervision requirements for low-dose CT services performed as part of mobile screening services for the NLCSP

Mobile screening services will be used in remote areas, more than 30km from fixed radiology infrastructure. Mobile screening will be used to support eligible participants who do not have access to fixed radiology infrastructure. In these circumstances low-dose CT scans for the NLCSP can be performed without the supervision of a radiologist. The low-dose CT scan can be conducted by a radiographer in these circumstances.

Related Items: 57410 57413